Information  X 
Enter a valid email address

BioPharma Credit PLC (BPCR)

  Print      Mail a friend

Monday 12 August, 2019

BioPharma Credit PLC

Notice of Interim Results

RNS Number : 6203I
BioPharma Credit PLC
12 August 2019

12 August 2019


("The Company") 


BioPharma Credit PLC (LSE: BPCR), the specialist life sciences debt investor, will announce its audited Half Year Results for the period ending 30 June 2019, on Wednesday 4 September 2019.

A management presentation will be held at 09:30am at Buchanan, 107 Cheapside, EC2V 6DN. A conference call facility will also be available.

To confirm your attendance, or request conference call details, RSVP to [email protected].



 BioPharma Credit PLC

via Link Company Matters Limited

Company Secretary

+44 (0) 1392 477 500



+44 (0)20 7466 5000

David Rydell / Mark Court / Jamie Hooper / Henry Wilson

[email protected]

Notes to Editors:

BioPharma Credit PLC is London's only listed specialist investor in debt from the life sciences industry and joined the LSE on 27 March 2017. The Company seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. The Company seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.

LEI: 213800AV55PYXAS7SY24


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t